APA (7th ed.) Citation

AW, S., MTS, Y., AL, E., RL, B., Y, L., P, B., . . . MM, V. (2020). Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk. Transfusion medicine (Oxford, England), 30(4), 263. https://doi.org/10.1111/tme.12685

Chicago Style (17th ed.) Citation

AW, Shih, et al. "Utilising Red Cell Antigen Genotyping and Serological Phenotyping in Sickle Cell Disease Patients to Risk-stratify Patients for Alloimmunisation Risk." Transfusion Medicine (Oxford, England) 30, no. 4 (2020): 263. https://doi.org/10.1111/tme.12685.

MLA (9th ed.) Citation

AW, Shih, et al. "Utilising Red Cell Antigen Genotyping and Serological Phenotyping in Sickle Cell Disease Patients to Risk-stratify Patients for Alloimmunisation Risk." Transfusion Medicine (Oxford, England), vol. 30, no. 4, 2020, p. 263, https://doi.org/10.1111/tme.12685.